葡萄糖载体蛋白-1 (GLUT1) 在乳腺癌的预后值

Mehenaz Hanbazazh1, Abdulhadi Samman1, Saad Samargandy2

  • 1Department of Pathology, Faculty of Medicine, University of Jeddah, Jeddah, Saudi Arabia.

PubMed
概括

葡萄糖载体1 (GLUT1) 免疫表达在沙特乳腺癌患者中很常见. 更高的GLUT1水平与瘤的攻击性特征相关,表明其作为预后标记物的潜力.